Sort
15,440 grants matching “organoids”
DRUG DISCOVERY FOR DUCHENNE MUSCULAR DYSTROPHY USING AI/ML AND IPSC-DERIVED ORGANOIDS
$490,000Greenstone Biosciences, Inc. · · FY2024 · Defense Health Agency
Delineating developmental programs driving tumorigenesis in triple-negative breast cancer
$489,960Aaron M Newman · Stanford University · R01 · FY2024 · CA
The Regenerative Potential of Aqp2+ Progenitor Cells
$489,533Wenzheng Zhang · Albany Medical College · R01 · FY2025 · DK
Human cellular models of TB and innate immunity
$489,500Anne Goldfeld · Boston Children'S Hospital · R21 · FY2025 · AI
Lymphoid Experimental Therapeutics Platform to Study Cooperative Signaling inHuman Lymphomas
$489,269Ankur Singh · Georgia Institute Of Technology · R01 · FY2020 · CA
Towards a complete characterization of the metastasis founder clones in colorectal cancer
$489,231Kamila Naxerova · Harvard Medical School · R01 · FY2025 · CA
Genetic requirements of Helicobacter pylori infection
$489,160Nina Reda Salama · Fred Hutchinson Cancer Center · R01 · FY2025 · AI
The role of the senescent microenvironment on cancer initiating cells in the colon.
$489,084William M Grady · Fred Hutchinson Cancer Center · U01 · FY2023 · AG
Role of Metalloproteinases in Mammary Gland Remodeling
$489,015University Of California San Francisco · R01 · FY2003 · CA
Identification and characterization of cellular factors involved in HCV entry
$488,913Charles M. Rice · Rockefeller University · R01 · FY2012 · AI
ERβ repurposes EZH2 to suppress oncogenic NFκB signaling in TNBC
$488,900John R Hawse · Mayo Clinic Rochester · R01 · FY2025 · CA
The selective advantage of mismatch repair loss in colonic stem cells
$488,887Christopher D. Heinen · University Of Connecticut Sch Of Med/Dnt · R01 · FY2021 · CA
Osteogenic Niche Biology in Progression and Endocrine Resistance of Bone Metastases
$488,881David R Rowley · Baylor College Of Medicine · R01 · FY2020 · CA
Osteogenic Niche Biology in Progression and Endocrine Resistance of Bone Metastases
$488,881David R Rowley · Baylor College Of Medicine · R01 · FY2018 · CA
Osteogenic Niche Biology in Progression and Endocrine Resistance of Bone Metastases
$488,881David R Rowley · Baylor College Of Medicine · R01 · FY2021 · CA
Study the pathogenesis of neurological disorders using human neural cultures derived from patient peripheral blood CD34 cells
$488,821Avindra Nath · National Institute Of Neurological Disorders And Stroke · ZIA · FY2018 · NS
Wnt Pathway Regulation of Gastric Stem Cell Function
$488,783Linda C Samuelson · University Of Michigan At Ann Arbor · R01 · FY2024 · DK
Guided Intracellular Delivery using Precise Area Introduction and Transfection (PAINT)
$488,753Andrei G Fedorov · Georgia Institute Of Technology · R01 · FY2024 · GM
Role of Metalloproteinases in Mammary Gland Remodeling
$488,744University Of California San Francisco · R01 · FY2004 · CA
The Evaluation of Novel Therapeutics for Genitourinary Malignancies
$488,637William Laurence Dahut · Division Of Clinical Sciences - Nci · ZIA · FY2020 · CA
Mechanisms mediating podocyte-parietal epithelial cell crosstalk in proliferative glomerulopathies
$488,558Sandeep K Mallipattu · State University New York Stony Brook · R01 · FY2024 · DK
Novel Approaches for Improving Inflammation Resolution Following Chronic Exposure to Air Pollutants
$488,553Srinivasa Reddy · University Of California Los Angeles · R01 · FY2022 · ES
Hybrid Synthetic and Biologic Shear Thinning Hydrogels for Diabetic Wound Healing
$488,507Craig Lewis Duvall · Vanderbilt University · R01 · FY2019 · EB
Truncated O-glycan-dependent mechanisms inducing metastatic dissemination in pancreatic cancer
$488,488Moorthy P. Ponnusamy · University Of Nebraska Medical Center · R01 · FY2024 · CA
Defining Mechanisms of Progression and Treatment Resistance in Localized Bladder Cancer
$488,477Eugene Pietzak · Sloan-Kettering Inst Can Research · R37 · FY2024 · CA